Literature DB >> 24150601

Increased lung cancer risk among patients with pneumococcal pneumonia: a nationwide population-based cohort study.

Te-Yu Lin1, Wen-Yen Huang, Jung-Chung Lin, Cheng-Li Lin, Fung-Chang Sung, Chia-Hung Kao, Jun-Jun Yeh.   

Abstract

BACKGROUND: The possible effects of pneumonia on subsequent lung cancer have been reported, but no relevant publications have focused on the association between pneumococcal pneumonia and lung cancer. The purpose of this study was to perform a nationwide population-based cohort study to investigate the risk of lung cancer after pneumococcus infection.
METHODS: This nationwide population-based cohort study was based on data obtained from the Taiwan National Health Insurance Database. In total, 22,034 pneumococcal pneumonia patients and 88,136 controls, matched for age and sex, were recruited for the study from 1997 to 2010.
RESULTS: The incidence rate of lung cancer (28.2 per 1,000 person-years) was significantly higher in pneumococcal pneumonia patients than in controls (8.7 per 1,000 person-years; incidence rate ratio, 3.25; 95 % confidence interval, 3.09-3.42; p < 0.001). Cox proportional hazards regression analysis showed a hazard ratio of 4.24 (95 % confidence interval, 3.96-4.55) for the pneumococcal pneumonia cohort after adjustment for age, gender, and comorbidities.
CONCLUSIONS: Pneumococcal pneumonia is associated with an increased risk of lung cancer. Thus, physicians should remain aware of this association when assessing patients with pneumococcal pneumonia.

Entities:  

Mesh:

Year:  2013        PMID: 24150601     DOI: 10.1007/s00408-013-9523-z

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  33 in total

1.  Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer.

Authors:  L A Jackson; S P Wang; V Nazar-Stewart; J T Grayston; T L Vaughan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-11       Impact factor: 4.254

2.  Chlamydia pneumoniae infection and risk for lung cancer.

Authors:  Anil K Chaturvedi; Charlotte A Gaydos; Patricia Agreda; Jeffrey P Holden; Nilanjan Chatterjee; James J Goedert; Neil E Caporaso; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

3.  Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk.

Authors:  Matthew B Schabath; George L Delclos; Marek M Martynowicz; Anthony J Greisinger; Charles Lu; Xifeng Wu; Margaret R Spitz
Journal:  Am J Epidemiol       Date:  2005-03-01       Impact factor: 4.897

4.  Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting.

Authors:  Richard M Peek; Suresh Mohla; Raymond N DuBois
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

5.  Never smokers and lung cancer risk: a case-control study of epidemiological factors.

Authors:  Olga Y Gorlova; Yiqun Zhang; Matthew B Schabath; Lei Lei; Qing Zhang; Christopher I Amos; Margaret R Spitz
Journal:  Int J Cancer       Date:  2006-04-01       Impact factor: 7.396

6.  Malignancies associated with systemic lupus erythematosus in Taiwan: a nationwide population-based cohort study.

Authors:  Ji-An Liang; Li-Min Sun; Jun-Jun Yeh; Wan-Yu Lin; Shih-Ni Chang; Hung-Chang Sung; Chia-Hung Kao
Journal:  Rheumatol Int       Date:  2010-12-31       Impact factor: 2.631

7.  Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study.

Authors:  Yang-Hao Yu; Chien-Chang Liao; Wu-Huei Hsu; Hung-Jen Chen; Wei-Chih Liao; Chih-Hsin Muo; Fung-Chang Sung; Chih-Yi Chen
Journal:  J Thorac Oncol       Date:  2011-01       Impact factor: 15.609

8.  Blood pressure, smoking, and the incidence of lung cancer in hypertensive men in North Karelia, Finland.

Authors:  Annamarja Lindgren; Eero Pukkala; Aulikki Nissinen; Jaakko Tuomilehto
Journal:  Am J Epidemiol       Date:  2003-09-01       Impact factor: 4.897

9.  Gender differences in smoking behaviors in an Asian population.

Authors:  Yi-Wen Tsai; Tzu-I Tsai; Chung-Lin Yang; Ken N Kuo
Journal:  J Womens Health (Larchmt)       Date:  2008 Jul-Aug       Impact factor: 2.681

10.  Metabolic syndrome and cancer risk.

Authors:  Antonio Russo; Mariangela Autelitano; Luigi Bisanti
Journal:  Eur J Cancer       Date:  2007-12-04       Impact factor: 9.162

View more
  12 in total

Review 1.  Microbiota dysbiosis in select human cancers: Evidence of association and causality.

Authors:  Jie Chen; Jada C Domingue; Cynthia L Sears
Journal:  Semin Immunol       Date:  2017-08-16       Impact factor: 11.130

2.  The characterization of lung microbiome in lung cancer patients with different clinicopathology.

Authors:  Danhui Huang; Xiaofang Su; Man Yuan; Shujia Zhang; Jing He; Qiuhua Deng; Wenjun Qiu; Hangming Dong; Shaoxi Cai
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

3.  Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients.

Authors:  Minglei Zhuo; Tongtong An; Chaoting Zhang; Ziping Wang
Journal:  Front Oncol       Date:  2020-08-24       Impact factor: 6.244

4.  Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.

Authors:  Ming-Fang Wu; Zhi-Hong Jian; Jing-Yang Huang; Cheng-Feng Jan; Oswald Ndi Nfor; Kai-Ming Jhang; Wen-Yuan Ku; Chien-Chang Ho; Chia-Chi Lung; Hui-Hsien Pan; Min-Chen Wu; Yung-Po Liaw
Journal:  BMC Cancer       Date:  2016-10-10       Impact factor: 4.430

5.  Systems Biology Approaches for the Prediction of Possible Role of Chlamydia pneumoniae Proteins in the Etiology of Lung Cancer.

Authors:  Shahanavaj Khan; Ahamad Imran; Abdul Arif Khan; Mohd Abul Kalam; Aws Alshamsan
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 6.  Lung cancer: a new frontier for microbiome research and clinical translation.

Authors:  Luis Aj Mur; Sharon A Huws; Simon Js Cameron; Paul D Lewis; Keir E Lewis
Journal:  Ecancermedicalscience       Date:  2018-09-05

7.  Increased Risk of Acute Kidney Injury following Pneumococcal Pneumonia: A Nationwide Cohort Study.

Authors:  Te-Yu Lin; Yu-Guang Chen; Cheng-Li Lin; Chia-Hung Kao
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

8.  The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous cell carcinoma.

Authors:  Zhi-Hong Jian; Jing-Yang Huang; Frank Cheau-Feng Lin; Oswald Ndi Nfor; Kai-Ming Jhang; Wen-Yuan Ku; Chien-Chang Ho; Chia-Chi Lung; Hui-Hsien Pan; Yu-Chiu Liang; Ming-Fang Wu; Yung-Po Liaw
Journal:  BMC Pulm Med       Date:  2015-12-03       Impact factor: 3.317

9.  Post-Inhaled Corticosteroid Pulmonary Tuberculosis Increases Lung Cancer in Patients with Asthma.

Authors:  Zhi-Hong Jian; Jing-Yang Huang; Frank Cheau-Feng Lin; Oswald Ndi Nfor; Kai-Ming Jhang; Wen-Yuan Ku; Chien-Chang Ho; Chia-Chi Lung; Hui-Hsien Pan; Min-Chen Wu; Ming-Fang Wu; Yung-Po Liaw
Journal:  PLoS One       Date:  2016-07-22       Impact factor: 3.240

10.  The TLR4/ERK/PD‑L1 axis may contribute to NSCLC initiation.

Authors:  Xiuhua Kang; Penghui Li; Chuibin Zhang; Yunshan Zhao; Huoli Hu; Guilan Wen
Journal:  Int J Oncol       Date:  2020-05-19       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.